open access publication

Article, 2023

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 0028-4793, Volume 388, 23, Pages 2145-2158, 10.1056/NEJMoa2216334

Contributors

Mirza, M. R. (Corresponding author) [1] [2] [3] Chase, D. 0000-0003-1075-4108 [4] [5] [6] [7] Slomovitz, B. M. [8] [9] [10] Christensen, R. dePont [11] Novak, Z. [12] Black, D. [13] [14] [15] Gilbert, Lucy 0000-0001-8605-5472 [16] Sharma, S. [17] Valabrega, G. [18] [19] [20] Landrum, L. M. [21] [22] Hanker, L. C. [23] [24] Stuckey, A. [25] Boere, I. [26] [27] [28] Gold, M. A. 0000-0002-0605-1971 [29] Auranen, A. [30] [31] Pothuri, Bhavana [32] Cibula, D. [33] [34] Mccourt, C. [35] Raspagliesi, F. 0000-0001-8953-1657 [36] [37] Shahin, M. S. [38] Gill, S. E. [39] Monk, Bradley J. [40] [41] Buscema, J. [42] Herzog, Thomas [43] [44] Copeland, L. J. [44] [45] [46] Tian, M. [47] He, Z. [47] Stevens, Sebastian 0000-0003-4997-2591 [48] Zografos, E. [48] Coleman, Robert 0000-0001-9343-8754 [49] Powell, M. A. [35] [50] [51] RUBY Investigators

Affiliations

  1. [1] Nord Soc Gynaecol Oncol, Clin Trial Unit, Copenhagen, Denmark
    2. [NORA names: Miscellaneous; Denmark; Europe, EU; Nordic; OECD];
  2. [2] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark
    3. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
  3. [3] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark
    4. [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
  4. [4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
    5. [NORA names: United States; America, North; OECD];
  5. [5] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
    6. [NORA names: United States; America, North; OECD];

Abstract

BACKGROUND Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell death 1 receptor. The combination of chemotherapy and immunotherapy may have synergistic effects in the treatment of endometrial cancer.

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+